抗精神病药物合并无抽搐电休克治疗难治性精神分裂症的临床研究  

Clinical Research of Antipsychotic Drugs with Electroconvulsive Therapy in Refractory Schizophrenia

作　　者：孙海琼[1] 欧汝奋[1] 罗一玲[1] 

机构地区：[1]广东省湛江中心人民医院,广东湛江524037

出　　处：《中国医药指南》2012年第15期432-433,共2页Guide of China Medicine

摘　　要：目的分析抗精神病药物联合应用无抽搐电休克(MECT)来治疗难治性精神分裂症病患的临床疗效以及安全性。方法对84例难治性精神分裂症病患的临床治疗资料进行回顾性分析。结果总有效率为83.3%;阴、阳性症状的量表评分、副反应量表的最终评分结果全部显示无明显变化、韦氏记忆量表等结果显示疗效显著。结论抗精神病药物合并无抽搐电休克治疗难治性精神分裂症,疗效显著,安全性相对高,值得临床推广使用。Objective To analyze the combination of antipsychotic non-convulsive electric shock（MECT） to treat patients with refractory schizophrenia clinical efficacy and safety.Methods 84 cases of refractory schizophrenia patients clinical data were retrospectively analyzed.Results The total effective rate was 83.3%;positive and negative symptoms scale score,side effects scale of the final score and all the results show no significant change,Wechsler Memory Scale,etc.The results showed a significant effect.Conclusion antipsychotics combined non-convulsive electric shock treatment of refractory schizophrenia,a significant effect,the relatively high security,worthy of clinical use.

关 键 词：精神分裂症 无抽搐电休克 

分 类 号：R749.3[医药卫生—神经病学与精神病学]